Keryx Biopharmaceuticals Inc (KERX)

Add to Watchlists
Create an Alert
3.15 -0.07  -2.17% NASDAQ Oct 15, 16:58 Delayed 2m USD

Keryx Biopharmaceuticals Inc Cash from Operations (TTM):

-104.12M for June 30, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Keryx Biopharmaceuticals Inc Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Keryx Biopharmaceuticals Inc Historical Cash from Operations (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2018 -104.12M
March 31, 2018 -100.96M
Dec. 31, 2017 -93.49M
Sept. 30, 2017 -93.66M
June 30, 2017 -88.16M
March 31, 2017 -84.84M
Dec. 31, 2016 -86.60M
Sept. 30, 2016 -90.84M
June 30, 2016 -96.01M
March 31, 2016 -119.91M
Dec. 31, 2015 -127.46M
Sept. 30, 2015 -136.47M
June 30, 2015 -127.43M
March 31, 2015 -106.23M
Dec. 31, 2014 -81.00M
Sept. 30, 2014 -59.65M
June 30, 2014 -52.51M
March 31, 2014 -42.23M
Dec. 31, 2013 -34.32M
Sept. 30, 2013 -27.64M
June 30, 2013 -21.84M
March 31, 2013 -18.35M
Dec. 31, 2012 -24.76M
Sept. 30, 2012 -26.82M
June 30, 2012 -27.07M
   
March 31, 2012 -25.95M
Dec. 31, 2011 -22.82M
Sept. 30, 2011 -21.38M
June 30, 2011 -17.30M
March 31, 2011 -18.03M
Dec. 31, 2010 -16.21M
Sept. 30, 2010 -13.73M
June 30, 2010 -10.50M
March 31, 2010 -9.069M
Dec. 31, 2009 -5.516M
Sept. 30, 2009 -5.156M
June 30, 2009 -12.66M
March 31, 2009 -15.23M
Dec. 31, 2008 -38.73M
Sept. 30, 2008 -41.08M
June 30, 2008 -51.24M
March 31, 2008 -65.77M
Dec. 31, 2007 -57.54M
Sept. 30, 2007 -64.65M
June 30, 2007 -58.74M
March 31, 2007 -54.78M
Dec. 31, 2006 -52.20M
Sept. 30, 2006 -49.05M
June 30, 2006 -44.10M
March 31, 2006 -33.42M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Advertisement

KERX Cash from Operations (TTM) Benchmarks

Benchmarks
Akebia Therapeutics Inc -82.33M
Processa Pharmaceuticals Inc -0.257M
Karyopharm Therapeutics Inc -99.57M

KERX Cash from Operations (TTM) Range, Past 5 Years

Minimum -136.47M Sep 2015
Maximum -34.32M Dec 2013
Average -90.84M

KERX Cash from Operations (TTM) Excel Add-In Codes

  • Metric Code: cash_operations_ttm
  • Latest data point: =YCP("KERX", "cash_operations_ttm")
  • Last 5 data points: =YCS("KERX", "cash_operations_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.